Court; John J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Court; John J..The latest application filed is for "substituted quinoxaline dna-pk inhibitors".
Company Profile
10.21.25
- Court; John J. - Littleton MA
- Court; John J. - Colonie NY
Patent Activity
| Patent | Date |
|---|---|
| Substituted Quinoxaline Dna-pk Inhibitors App 20210236505 - Maxwell; John Patrick ; et al. | 2021-08-05 |
| Substituted quinoxaline DNA-PK inhibitors Grant 10,973,830 - Maxwell , et al. April 13, 2 | 2021-04-13 |
| Dna-pk Inhibitors App 20210069203 - Maxwell; John Patrick ; et al. | 2021-03-11 |
| Inhibitors of influenza viruses replication Grant 10,874,673 - Charifson , et al. December 29, 2 | 2020-12-29 |
| DNA-PK inhibitors Grant 10,786,512 - Maxwell , et al. September 29, 2 | 2020-09-29 |
| Dna-pk Inhibitors App 20190290654 - Maxwell; John Patrick ; et al. | 2019-09-26 |
| Dna-pk Inhibitors App 20190255062 - Maxwell; John Patrick ; et al. | 2019-08-22 |
| Process For The Preparation Of A 1,3-disubstituted Pyrazole Compound App 20190177295 - Bligh; Cavan McKeon ; et al. | 2019-06-13 |
| Inhibitors Of Influenza Viruses Replication App 20190151314 - Charifson; Paul S. ; et al. | 2019-05-23 |
| DNA-PK inhibitors Grant 10,258,627 - Maxwell , et al. | 2019-04-16 |
| Dna-pk Inhibitors App 20180311254 - Maxwell; John Patrick ; et al. | 2018-11-01 |
| 1,3-substituted Pyrazole Compounds Useful For Reduction Of Very Long Chain Fatty Acid Levels App 20180251431 - Charifson; Paul S. ; et al. | 2018-09-06 |
| Inhibitors of influenza viruses replication Grant 10,039,762 - Charifson , et al. August 7, 2 | 2018-08-07 |
| Dna-pk Inhibitors App 20180161336 - Maxwell; John Patrick ; et al. | 2018-06-14 |
| Substituted benzooxadiazole DNA-PK inhibitors Grant 9,987,284 - Maxwell , et al. June 5, 2 | 2018-06-05 |
| Inhibitors Of Influenza Viruses Replication App 20180078553 - Charifson; Paul S. ; et al. | 2018-03-22 |
| Inhibitors of influenza viruses replication Grant 9,808,459 - Charifson , et al. November 7, 2 | 2017-11-07 |
| Inhibitors Of Influenza Viruses Replication App 20170100400 - Charifson; Paul S. ; et al. | 2017-04-13 |
| Inhibitors of influenza viruses replication Grant 9,518,056 - Charifson , et al. December 13, 2 | 2016-12-13 |
| Dna-pk Inhibitors App 20160354381 - Maxwell; John Patrick ; et al. | 2016-12-08 |
| Dna-pk Inhibitors App 20160340341 - Maxwell; John Patrick ; et al. | 2016-11-24 |
| DNA-PK inhibitors Grant 9,359,380 - Maxwell , et al. June 7, 2 | 2016-06-07 |
| Inhibitors Of Influenza Viruses Replication App 20160152614 - Charifson; Paul S. ; et al. | 2016-06-02 |
| Inhibitors of influenza viruses replication Grant 9,345,708 - Charifson , et al. May 24, 2 | 2016-05-24 |
| Substituted quinoxaline DNA-PK inhibitors Grant 9,340,557 - Maxwell , et al. May 17, 2 | 2016-05-17 |
| Inhibitors Of Influenza Viruses Replication App 20140296201 - Charifson; Paul S. ; et al. | 2014-10-02 |
| Inhibitors of influenza viruses replication Grant 8,829,007 - Charifson , et al. September 9, 2 | 2014-09-09 |
| Inhibitors Of Influenza Viruses Replication App 20140142119 - Charifson; Paul S. ; et al. | 2014-05-22 |
| Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20140031277 - Cottrell; Kevin M. ; et al. | 2014-01-30 |
| Compounds And Methods For The Treatment Or Prevention Of Flavivirus Infections App 20130190289 - Green; Jeremy ; et al. | 2013-07-25 |
| Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20130116169 - Perni; Robert B. ; et al. | 2013-05-09 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,217,048 - Perni , et al. July 10, 2 | 2012-07-10 |
| Inhibitors Of Influenza Viruses Replication App 20120171245 - Charifson; Paul S. ; et al. | 2012-07-05 |
| Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20110104115 - Perni; Robert B. ; et al. | 2011-05-05 |
| Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20100330109 - Cottrell; Kevin M. ; et al. | 2010-12-30 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,745,444 - Perni , et al. June 29, 2 | 2010-06-29 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,683,033 - Cottrell , et al. March 23, 2 | 2010-03-23 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20080311079 - Perni; Robert B. ; et al. | 2008-12-18 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,378,422 - Perni , et al. May 27, 2 | 2008-05-27 |
| Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050137139 - Perni, Robert B. ; et al. | 2005-06-23 |
| 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof Grant 5,750,550 - Eissenstat , et al. May 12, 1 | 1998-05-12 |
| Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof Grant 5,541,168 - Court , et al. July 30, 1 | 1996-07-30 |
| 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof Grant 5,494,925 - Court , et al. February 27, 1 | 1996-02-27 |
| 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof Grant 5,488,062 - Dunlap , et al. January 30, 1 | 1996-01-30 |
| 2-saccharinylmethyl aryl carboxylate Grant 5,250,696 - Dunlap , et al. October 5, 1 | 1993-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 